Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

Dec. 13, 1996

Biogen, Creative BioMolecules to codevelop drugs for renal disorders

Dec. 12, 1996

cGMP-PDE inhibitors revealed by Fujisawa

Dec. 11, 1996

P&U anticipates filing for urinary incontinence treatment soon

Dec. 10, 1996

Merck & Co. reveals new agents for BPH

Dec. 10, 1996

VIP analogs and derivatives claimed for smooth muscle relaxation

Dec. 9, 1996

Sepracor gets go-ahead for U.S. clinical trials on (S)-oxybutynin

Dec. 6, 1996

Synsorb Pk licensed to major Japanese pharmaceutical company

Dec. 4, 1996

Chugai starts phase I clinical trials with phosphate binder

Dec. 4, 1996

Negative clinical results reported for aromatase inhibitor in BPH

Nov. 29, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...